Customized in silico population mimics a
✍
Susan F. Hudachek; Daniel L. Gustafson
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 299 KB
Population pharmacokinetic (PK) analyses have been successfully incorporated into drug dosing optimization; however, these analyses necessitate relatively large patient cohorts that many clinical trials do not have the luxury of affording. To address this problem, we developed an approach that utili